Prevention: The Best Offensive Line

The best offense — our most powerful tool – to combat heart disease is prevention. Fittingly, this theme, along with innovation, is embedded in the ACC.19 education and science programming.

The Prevention Learning Pathway has been crafted to provide reviews and deep dives into the practice-changing science prompting new guidelines and consensus decisions. The Prevention Pathway will provide every member of the cardiovascular care team with guidance on adjusting their patients' care based on the new information, research results and the availability of newer pharmaceuticals and technology.

Key topics such as diabetes management and cardiovascular disease; newer therapeutics in lipid lowering and inflammation; the microbiome; aspirin therapy; smoking; diet and lifestyle; informatics and novel apps and more will be tackled in sessions with a blend of case discussions, debates and knowledge checks.

At ACC.19, 15 different sessions will provide reviews and deep dives into all the major guidelines, including the recent high blood pressure guideline, cholesterol guideline and the hot-off-the-press focused update of the atrial fibrillation guideline.

Here's a roundup of key events and sessions. Click here for all the offerings from the Prevention Learning Pathway and what it means for your patients.

Primary Prevention in the Spotlight

Following on the heels of the Apple Heart Study and an expert panel discussing the future of digital technologies in preventing and treating heart disease on Saturday, don't miss the rollout of the ACC/AHA Guideline for the Primary Prevention of Cardiovascular Disease (Session 744) on Sunday, March 17.

Keeping with an underlying theme of prevention universal throughout ACC.19, this much-anticipated guideline will provide a comprehensive yet targeted set of lifestyle recommendations to guide clinicians to provide the best evidence-based care in adults. Attendees can also dive deeper into the components of the new guideline and implementing it in practice on Monday (Session 775).

Guideline Sessions Not to be Missed

Learn from the experience of your colleagues how clinical guidelines translate into daily clinical practice. ACC.19 covers the full spectrum of guidelines from ACS, prevention, cholesterol, hypertension, syncope, echo and more.

2018 Cholesterol Guideline

  • Session 636 Just Tell Me the Fa(c)ts About the New Cholesterol Guideline!
  • Session 706 Great Debates in Clinical Lipidology in 2019
  • Session 759 The Devil Is in the Details: A Case-Based Discussion on Cholesterol Guidelines

2017 High Blood Pressure Guideline

  • Session 760 Beyond the New Hypertension Guidelines: Understanding and Implementing in Current Practice

2019 Atrial Fibrillation Guideline Focused Update

  • Session 608 Contemporary Treatment of Atrial Fibrillation in 2019 – Thromboembolic Risk Reduction, Ablation and Prevention: Joint Symposium of the Heart Rhythm Society and the American College of Cardiology

2018 Bradycardia Guideline

  • Session 658 Parsing the Guidelines: New Insights on Bradycardia, Ventricular Arrhythmias, Lead Management and Arrhythmogenic Cardiomyopathies

2017 Heart Failure Guideline Focused Update

  • Session 661 Kanu and Docey Chatterjee Keynote and Seminal Talks in Heart Failure: Guidelines, Challenges, and Pathway for Success: Learn from the Experts

2017 Syncope Guideline

  • Session 624 ACC/AHA/HRS and ESC Guidelines on Syncope: Case-based Studies

Multiple Guidelines: Guideline-Directed Medical Therapy

  • Session 680 New Paradigms in Contemporary Cardiovascular Care: Application of Guideline-Directed Therapies – Implications for Minority Populations and Resolution of Disparities: Joint Symposium of the Association of Black Cardiologists and the ACC
  • Session 735 Controversies in ACS Guidelines and Actual Care: What the Experts Don't Always Tell You

More Prevention Highlights

Don't miss these hot topics:

  • Session 668 Can We Optimize CVD Care Using Genetics, Digital Health and the Microbiome?
  • Session #679 Changing Paradigm in Cardiovascular Risk Reduction in Diabetes
  • Session 718 LDL-C and Beyond: Harnessing the Power of Novel Therapeutic Targets and Big Data to Improve Dyslipidemia Care
  • Session 619 Hypertension Management Hypercharged: The Devil is in the Details
  • Session 653 So You Know Your Lipids! Let's do Some Questions and Discuss Some Cases

Late-Breaking Clinical Trials in Prevention

Session 409 Mark your calendar to hear this late-breaking science on Monday, March 18, from 8:00 a.m. – 9:15 a.m.

  • CLEAR Wisdom Trial: Efficacy and Safety of Bempedoic Acid Added to Maximally Tolerated Statins in Patients with Hypercholesterolemia and High Cardiovascular Risk
  • CREOLE Study: Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans
  • INFINITY: Primary Results of the Intensive vs. Standard Ambulatory Blood Pressure Lowering to Lessen Functional Decline in the Elderly Trial
  • DECLARE: Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus Based on Ejection Fraction
  • REDUCE-IT: Reduction in Total Ischemic Events with Icosapent Ethyl in REDUCE-IT

Engaging Our Patients and Their Caregivers

Patients and their families and caregivers are the foundation of the team work needed to prevent heart disease and achieve the best outcomes. CardioSmart provides the information and support needed to engage and inform these crucial members of the team.

By signing up, they can also receive personalized news and health tips and they can set health goals and track their progress.

Look for patient-facing guideline summaries, decision aids, infographics, and more.

Download these infographics and more from today!

Tools and Resources: ACC's Guideline Hubs

COUNT ON ACC to provide all the tools and resources you need to successfully implement all the guidelines in your daily practice.

From quick reference guides that break the guidelines down into easy-to-use summaries, key points to remember, pocket cards and more to slide sets and perspectives that provide guideline commentary, you'll find it on the Guidelines Hub.

Look for the apps and tools created to support critical decision-making at the point of care. And link to a range of patient resources.

Look for the Prevention Guidelines Hub on immediately after the rollout presentation on Sunday for tools and resources for clinicians and patients.

Access the Hub for the full document, Guidelines Made Simple, updated apps, infographics, and more. It's the one-stop-shop to put prevention into practice!

Find it all at

Interested in Prevention? Become a Section Member

ACC's Prevention of Cardiovascular Disease Member Section and Leadership Council is the home for prevention professionals within the ACC, advocating for and advancing the priorities of the community.

Combining a unique blend of forum and network, the Section serves as a College-wide resource for issues related to the prevention of cardiovascular disease.

Click here to learn more and join.

Join the Conversation

Follow @ACCinTouch on Twitter and use the #cvPrev hashtag. Plus, follow @avolgman for live tweeting from the Prevention Learning Pathway.

Keywords: ACC Publications, Cardiology Magazine, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypercholesterolemia, Cardiovascular Diseases, Malus, Aspirin, Atrial Fibrillation, Diabetes Mellitus, Type 2, Bradycardia, Caregivers, Point-of-Care Systems, Leadership, Goals, Stroke Volume, Risk Factors, Cholesterol, Eicosapentaenoic Acid, Primary Prevention, Heart Failure, Cardiomyopathies, Syncope, Hypertension, Life Style, Risk Reduction Behavior, Diet, Decision Support Techniques, Inflammation, Microbiota, Smoking, Pharmaceutical Preparations, ACC19

< Back to Listings